Floyd Robert Michael 4

4 · Processa Pharmaceuticals, Inc. · Filed Jul 9, 2021

Insider Transaction Report

Form 4
Period: 2021-07-08
Floyd Robert Michael
Chief Operating Officer
Transactions
  • Award

    Restricted Stock Units

    2021-07-08+12,85812,858 total
    Exercise: $0.00Common Stock (12,858 underlying)
  • Award

    Restricted Stock Units

    2021-07-08+8,5728,572 total
    Exercise: $0.00Common Stock (8,572 underlying)
  • Award

    Restricted Stock Units

    2021-07-08+1,90710,034 total
    Exercise: $0.00Common Stock (10,034 underlying)
Footnotes (3)
  • [F1]The restricted stock units vest in two equal installments beginning July 1, 2022.
  • [F2]The Restricted Stock Units vest upon achievement of certain performance goals.
  • [F3]Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4